logo
12:34 Dec 05

Divi's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6455.00
-14.00 (-0.22%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Divi's Laboratories Ltd. Financials

Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6455.00
-14.00 (-0.22%)
12:34 Dec 05
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

26/100
Expensive Valuation

Technical

48/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

1

Threats

0

14.63 %

ROE %

12.93 %

ROA %

93.61

EPS

564.87

BVPS

23.40 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
8959.83 7767.51 7845 9360 9652
Operating Expenses +
5077.89 5399.69 5640 6392 6578
Raw Material
3490.97 3030.69 3238 3821 3938
Increase Decrease in Cost
-523.83 23.03 -109 -96 -110
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
946.16 975.02 1094 1243 1291
Miscellaneous Expenses
1193.41 1415.61 1429 1424 1459
Operating Profit
3881.94 2367.82 2205 2968 3074
Other Income
113.87 344.66 339 352 393
Depreciation
311.51 343.18 378 402 417
Interest
0.8 0.67 3 2 5
Profit before tax and exceptio..
3683.5 2368.63 2163 2916 3045
Exceptional Items
0 0 0 0 0
PBT
3683.5 2368.63 2163 2916 3045
Provision for Taxation
723.05 545.25 563 725 739
Net Profit
2960.45 1823.38 1600 2191 2306
NET Profit after MI
2960.45 1823.38 1600 2191 2306
EPS
111.52 68.69 60.27 82.53 86.82
Operating Profit Margin (%)
43.33 30.48 28.11 31.71 31.85
Net Profit Margin (%)
33.04 23.47 20.4 23.41 23.89

Divi's Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 51.90 51.90 51.90 51.90 51.90 51.90
FII 19.40 19.70 18.00 18.00 17.20 16.20
Public 19.80 19.10 20.70 20.50 21.10 21.70
Others 8.90 9.30 9.40 9.60 9.80 10.20
Shareholder Shares Holding %
Research 360 logo
Download Our App On: